Host: |
Rabbit |
Applications: |
WB/IHC-P |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit monoclonal antibody anti-SCIN (669-682 aa) is suitable for use in Western Blot and Immunohistochemistry research applications. |
Clonality: |
Monoclonal |
Clone ID: |
R07-6G2 |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
50mM Tris-Glycine (pH7.4) , 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA |
Purification: |
Affinity Purified |
Concentration: |
0.3 mg/ml |
Dilution Range: |
WB 1:500-1:1000IHC 1:50-1:100 |
Storage Instruction: |
Store at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles. |
Gene Symbol: |
SCIN |
Gene ID: |
85477 |
Uniprot ID: |
SCIN_HUMAN |
Immunogen Region: |
669-682 aa |
Immunogen: |
A synthetic peptide of human SCIN |
Tissue Specificity | Expressed in megakaryocytes. |
Function | Ca(2+)-dependent actin filament-severing protein that has a regulatory function in exocytosis by affecting the organization of the microfilament network underneath the plasma membrane. Severing activity is inhibited by phosphatidylinositol 4,5-bis-phosphate (PIP2). In vitro, also has barbed end capping and nucleating activities in the presence of Ca(2+). Required for megakaryocyte differentiation, maturation, polyploidization and apoptosis with the release of platelet-like particles. Plays a role in osteoclastogenesis (OCG) and actin cytoskeletal organization in osteoclasts. Regulates chondrocyte proliferation and differentiation. Inhibits cell proliferation and tumorigenesis. Signaling is mediated by MAPK, p38 and JNK pathways. |
Protein Name | ScinderinAdseverin |
Cellular Localisation | CytoplasmCytoskeletonCell ProjectionPodosome |
Alternative Antibody Names | Anti-Scinderin antibodyAnti-Adseverin antibodyAnti-SCIN antibodyAnti-KIAA1905 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance